Table 1.
Demographic and clinical characteristics at baseline (N=8)
| Characteristics | Patients (N=8) |
|---|---|
| Patients (m/f) | 8 (1/7) |
| Male (%) | 12.5 |
| Age (years) | |
| Mean (SD) | 64.6 (12.1) |
| Median | 66 |
| Range | 46–80 |
| Disease duration (years) | |
| Mean (SD) | 20.9 (11.6) |
| Median | 19.5 |
| Range | 9–39 |
| Tender joint count | |
| Mean (SD) | 31.4 (16.3) |
| Median | 33.5 |
| Range | 7–50 |
| Swollen joint count | |
| Mean (SD) | 32.9 (10.74) |
| Median | 36 |
| Range | 17–48 |
| HAQ score | |
| Mean (SD) | 1.78 (0.71) |
| Median | 1.75 |
| Range | 0.875–2.75 |
| ESR (mm/h) | |
| Mean (SD) | 21.5 (16.5) |
| Median | 16 |
| Range | 7–60 |
| CRP (mg/L) | |
| Mean (SD) | 0.825 (0.6) |
| Median | 0.9 |
| Range | 0.1–1.8 |
| Patient VAS | |
| Mean (SD) | 40.1 (30.3) |
| Median | 28.5 |
| Range | 8–97 |
| Physician VAS | |
| Mean (SD) | 7.6 (2.2) |
| Median | 8.4 |
| Range | 3.8–9.9 |
| Disease activity score for RA (DAS28) | |
| Mean (SD) | 5.7 (0.84) |
| Median | 5.83 |
| Range | 4.33–6.87 |
Abbreviations: CRP, C-reactive protein; DAS28, disease activity score 28; ESR, erythrocyte sedimentation rate; f, female; HAQ, health assessment questionnaire; m, male; RA, rheumatoid arthritis; SD, standard deviation; VAS, visual analog scale.